Laust Dupont Rasmussen

Laust Dupont Rasmussen

Auto-generated profile, based on publicly available information

Laust Dupont Rasmussen

Department of Cardiology, Gødstrup Hospital , Hospitalsparken 15, 7400 Herning

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2020 in European Heart Journal
Verified
Journal Article
Closed access
SWSimon Winther
Simon Winther
SSSamuel Emil Schmidt
Samuel Emil Schmidt
LRLaust Dupont Rasmussen
Laust Dupont Rasmussen
Luis Eduardo Juarez-OrozcoLuis Eduardo Juarez-Orozco
Luis Eduardo Juarez-Orozco
FSFlemming Hald Steffensen
Flemming Hald Steffensen
MBMorten Bøttcher
Morten Bøttcher
Aims : Estimation of pre-test probability (PTP) of disease in patients with suspected coronary artery disease (CAD) is a common challenge. Due to decreasing prevalence of obstructive CAD in patients referred for diagnostic testing, the European Society of Cardiology suggested a new PTP (2019-ESC-PTP) model. The aim of this study was to validate that model. Methods and results : Symptomatic patients referred for coronary computed tomography angiography (CTA) due to suspected CAD in a geographical uptake area of 3.3 million inhabitants were included. The reference standard was a combined endpoint of CTA and invasive coronary angiography (ICA) with obstructive CAD defined at ICA as a ≥50% diameter stenosis or fractional flow reserve ≤0.80 when performed. The 2019-ESC-PTP, 2013-ESC-PTP, and CAD Consortium basic PTP scores were calculated based on age, sex, and symptoms. Of the 42 328 identified patients, coronary stenosis was detected in 8.8% using the combined endpoint. The 2019-ESC-PTP and CAD Consortium basic scores classified substantially more patients into the low PTP groups (PTP < 15%) than did the 2013-ESC-PTP (64% and 65% vs. 16%, P < 0.001). Using the combined endpoint as reference, calibration of the 2019-ESC-PTP model was superior to the 2013-ESC-PTP and CAD Consortium basic score. Conclusion : The new 2019-ESC-PTP model is well calibrated and superior to the previously recommended models in predicting obstructive stenosis detected by a combined endpoint of CTA and ICA.

1 June 2018 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
SWSimon Winther
Simon Winther
MSMy Svensson
My Svensson
HJHanne Skou Joergensen
Hanne Skou Joergensen
LRLaust Dupont Rasmussen
Laust Dupont Rasmussen
NHNiels Ramsing Holm
Niels Ramsing Holm
MBMorten Bøttcher
Morten Bøttcher

8 February 2023 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
LRLaust Dupont Rasmussen
Laust Dupont Rasmussen
SWSimon Winther
Simon Winther
AEAshkan Eftekhari
Ashkan Eftekhari
SKSalma Raghad Karim
Salma Raghad Karim
JWJelmer Westra
Jelmer Westra
MBMorten Böttcher
Morten Böttcher

9 November 2017 in Heart
Verified
Journal Article
Open access
PDF file
SWSimon Winther
Simon Winther
LNLouise Nissen
Louise Nissen
SSSamuel Emil Schmidt
Samuel Emil Schmidt
JWJelmer Westra
Jelmer Westra
LRLaust Dupont Rasmussen
Laust Dupont Rasmussen
MBMorten Bøttcher
Morten Bøttcher
Objective Diagnosing coronary artery disease (CAD) continues to require substantial healthcare resources. Acoustic analysis of transcutaneous heart sounds of cardiac movement and intracoronary turbulence due to obstructive coronary disease could potentially change this. The aim of this study was thus to test the diagnostic accuracy of a new portable acoustic device for detection of CAD. Methods We included 1675 patients consecutively with low to intermediate likelihood of CAD who had been referred for cardiac CT angiography. If significant obstruction was suspected in any coronary segment, patients were referred to invasive angiography and fractional flow reserve (FFR) assessment. Heart sound analysis was performed in all patients. A predefined acoustic CAD-score algorithm was evaluated; subsequently, we developed and validated an updated CAD-score algorithm that included both acoustic features and clinical risk factors. Low risk is indicated by a CAD-score value ≤20. Results Haemodynamically significant CAD assessed from FFR was present in 145 (10.0%) patients. In the entire cohort, the predefined CAD-score had a sensitivity of 63% and a specificity of 44%. In total, 50% had an updated CAD-score value ≤20. At this cut-off, sensitivity was 81% (95% CI 73% to 87%), specificity 53% (95% CI 50% to 56%), positive predictive value 16% (95% CI 13% to 18%) and negative predictive value 96% (95% CI 95% to 98%) for diagnosing haemodynamically significant CAD. Conclusion Sound-based detection of CAD enables risk stratification superior to clinical risk scores. With a negative predictive value of 96%, this new acoustic rule-out system could potentially supplement clinical assessment to guide decisions on the need for further diagnostic investigation. Trial registration number ClinicalTrials.gov identifier NCT02264717; Results.

1 September 2019 in American Heart Journal
Verified
Journal Article
Open access
LRLaust Dupont Rasmussen
Laust Dupont Rasmussen
SWSimon Winther
Simon Winther
JWJelmer Westra
Jelmer Westra
CIChristin Isaksen
Christin Isaksen
JEJune Anita Ejlersen
June Anita Ejlersen
MBMorten Böttcher
Morten Böttcher
Coronary computed tomography angiography (CTA) is the preferred primary diagnostic modality when examining patients with low to intermediate pre-test probability of coronary artery disease (CAD). Only 20-30% of these have potentially obstructive CAD. Because of the relatively poor positive predictive value of coronary CTA, unnecessary invasive coronary angiographies (ICAs) are conducted with the costs and risks associated with the procedure. Hence, an optimized diagnostic CAD algorithm may reduce the numbers of ICAs not followed by revascularization. The Dan-NICAD 2 study has 3 equivalent main aims: (1) To examine the diagnostic precision of a sound-based diagnostic algorithm, The CADScor®System (Acarix A/S, Denmark), in patients with a low to intermediate pre-test risk of CAD referred to a primary examination by coronary CTA. We hypothesize that the CADScor®System provides better stratification prior to coronary CTA than clinical risk stratification scores alone. (2) To compare the diagnostic accuracy of 3T cardiac magnetic resonance imaging (3T CMRI), 82rubidium positron emission tomography (82Rb-PET), and CT-derived fractional flow reserve (FFRCT) in patients where obstructive CAD cannot be ruled out by coronary CTA using ICA fractional flow reserve (FFR) as reference standard. (3) To compare the diagnostic performance of quantitative flow ratio (QFR) and ICA-FFR in patients with low to intermediate pre-test probability of CAD using 82Rb-PET as reference standard. Dan-NICAD 2 is a prospective, multicenter, cross-sectional study including approximately 2,000 patients with low to intermediate pre-test probability of CAD and without previous history of CAD. Patients are referred to coronary CTA because of symptoms suggestive of CAD, as evaluated by a cardiologist. Patient interviews, sound recordings, and blood samples are obtained in connection with the coronary CTA. If coronary CTA does not rule out obstructive CAD, patients will be examined by 3T CMRI 82Rb-PET, FFRCT, ICA, and FFR. Reference standard is ICA-FFR. Obstructive CAD is defined as an FFR ≤0.80 or as high-grade stenosis (>90% diameter stenosis) by visual assessment. Diagnostic performance will be evaluated as sensitivity, specificity, predictive values, likelihood ratios, calibration, and discrimination. Enrolment started January 2018 and is expected to be completed by June 2020. Patients are followed for 10 years after inclusion. The results of the Dan-NICAD 2 study are expected to contribute to the improvement of diagnostic strategies for patients suspected of CAD in 3 different steps: risk stratification prior to coronary CTA, diagnostic strategy after coronary CTA, and invasive wireless QFR analysis as an alternative to ICA-FFR.

11 May 2022 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
LRLaust D. Rasmussen
Laust D. Rasmussen
CFChristopher B. Fordyce
Christopher B. Fordyce
LNLouise Nissen
Louise Nissen
CHC. Larry Hill
C. Larry Hill
BABrooke Alhanti
Brooke Alhanti
SWSimon Winther
Simon Winther